OurCrowd portfolio company ReWalk was featured in The Times of Israel, an English-language news website covering Israel, the region & the Jewish world. ReWalk is the developer of the FDA approved ReWalk exoskeleton device, providing paraplegics with an independent, natural walking experience that provides them numerous social, psychological, and physical benefits.
For quadriplegics, losing the use of their legs is not the end of their problems, according to ReWalk CFO Kevin Hirschberger.
“People with spinal cord injuries who are paralyzed below the waist have the same physical issues as everyone else, such as gaining weight if they eat too much and don’t exercise. With our ReWalk exoskeleton, patients can get the exercise their body needs, preventing severe conditions like heart problems, osteoporosis, kidney disease, and much more,” said Hirschberger.
ReWalk raised $1,320,000 from OurCrowd investors in June 2013.
Read more on The Times of Israel here.